HomeNewsBusinessReal EstateGovt’s decision to extend subsidy scheme up to March 2021 to boost affordable housing

Govt’s decision to extend subsidy scheme up to March 2021 to boost affordable housing

The extension is expected to support first time middle-class homebuyers and stimulates housing demand and ancillary sectors.

May 14, 2020 / 18:49 IST
Story continues below Advertisement
Representative image
Representative image

To push demand for affordable housing, Finance Minister Nirmala Sitharaman on May 14 announced a one-year extension of the Credit Linked Subsidy Scheme (CLSS) up to March 2021 and announced a Rs 70,000-crore boost to the residential sector.

The credit-linked subsidy scheme for the middle income group, with an annual income of Rs 6 lakh to Rs 18 lakh was operationalised from May 2017 and extended up to March 2020.

Story continues below Advertisement

The extension is expected to support first time middle-class homebuyers and stimulates housing demand and ancillary sectors.

The scheme is being extended by one year to benefit 2.5 lakh middle income families, she said, adding it has already benefited 3.3 lakh middle class families so far. “It will create jobs and stimulate demand for steel, cement, transport and other construction materials.”

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show